Status:
UNKNOWN
Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation
Lead Sponsor:
Deutsches Herzzentrum Muenchen
Conditions:
Ablation
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Catheter ablation with isolation of the pulmonary veins has proven to be an effective treatment option in patients with paroxysmal atrial fibrillation. In patients who have a relapse of paroxysmal atr...
Detailed Description
Catheter ablation with isolation of the pulmonary veins has proven to be an effective treatment option in patients with paroxysmal atrial fibrillation. In patients who have a relapse of paroxysmal atr...
Eligibility Criteria
Inclusion
- relapse of atrial fibrillation
Exclusion
- contraindication for ablation
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01229306
Start Date
July 1 2010
End Date
January 1 2014
Last Update
May 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Deutsches Herzzentrum
München, Bayer, Germany, 80636